[ad_1] The S&P 500 Index SPX, -1.85% hit resistance this week when an oversold rally failed near the 4080 level.…
Read More »Biopharmaceuticals
[ad_1] BridgeBio Pharma stock was soaring after the biopharmaceutical company reported positive results in a Phase two clinical trial for…
Read More »
[ad_1] Updated with month-end prices. The euphoria of January reversed in February, with broad declines for stocks across the board…
Read More »
[ad_1] This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients…
Read More »
[ad_1] An approval filing for a breakthrough treatment of sickle cell disease should be done by March, Crispr Therapeutics said,…
Read More »
[ad_1] Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA…
Read More »
[ad_1] Clovis Oncology Inc., maker of the ovarian and prostate cancer drug Rubraca, filed for bankruptcy over the weekend with…
Read More »
[ad_1] New York, New York–(Newsfile Corp. – December 6, 2022) – Levi & Korsinsky, LLP notifies investors in Eiger BioPharmaceuticals,…
Read More »
[ad_1] NEW YORK, Dec. 2, 2022/PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the…
Read More »
[ad_1] Sometimes, a single worry grows so large that it obscures all the good things happening at the same time.…
Read More »